GenomeNet

Database: UniProt
Entry: Q9NQ36
LinkDB: Q9NQ36
Original site: Q9NQ36 
ID   SCUB2_HUMAN             Reviewed;         999 AA.
AC   Q9NQ36; Q2NKQ8; Q6ZWI1;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   12-SEP-2018, sequence version 3.
DT   04-NOV-2026, entry version 179.
DE   RecName: Full=Signal peptide, CUB and EGF-like domain-containing protein 2 {ECO:0000303|PubMed:19480626};
DE   AltName: Full=Scube/You {ECO:0000250|UniProtKB:Q9JJS0};
DE   Flags: Precursor;
GN   Name=SCUBE2 {ECO:0000303|PubMed:12270931, ECO:0000312|HGNC:HGNC:30425};
GN   Synonyms=CEGP1 {ECO:0000303|PubMed:11528127};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=11528127; DOI=10.1159/000056999;
RA   Amid C., Bahr A., Mujica A., Sampson N., Bikar S.E., Winterpacht A.,
RA   Zabel B., Hankeln T., Schmidt E.R.;
RT   "Comparative genomic sequencing reveals a strikingly similar architecture
RT   of a conserved syntenic region on human chromosome 11p15.3 (including gene
RT   ST5) and mouse chromosome 7.";
RL   Cytogenet. Cell Genet. 93:284-290(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT MET-591.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=12270931; DOI=10.1074/jbc.m207410200;
RA   Yang R.-B., Ng C.K.D., Wasserman S.M., Colman S.D., Shenoy S., Mehraban F.,
RA   Koemueves L.G., Tomlinson J.E., Topper J.N.;
RT   "Identification of a novel family of cell-surface proteins expressed in
RT   human vascular endothelium.";
RL   J. Biol. Chem. 277:46364-46373(2002).
RN   [6]
RP   SUBCELLULAR LOCATION, SUBUNIT, INTERACTION WITH SHH AND PTCH1, FUNCTION,
RP   AND GLYCOSYLATION.
RX   PubMed=19480626; DOI=10.1042/bj20090341;
RA   Tsai M.T., Cheng C.J., Lin Y.C., Chen C.C., Wu A.R., Wu M.T., Hsu C.C.,
RA   Yang R.B.;
RT   "Isolation and characterization of a secreted, cell-surface glycoprotein
RT   SCUBE2 from humans.";
RL   Biochem. J. 422:119-128(2009).
RN   [7]
RP   FUNCTION, INTERACTION WITH SHH, AND SUBUNIT.
RX   PubMed=22902404; DOI=10.1016/j.celrep.2012.07.010;
RA   Tukachinsky H., Kuzmickas R.P., Jao C.Y., Liu J., Salic A.;
RT   "Dispatched and scube mediate the efficient secretion of the cholesterol-
RT   modified hedgehog ligand.";
RL   Cell Rep. 2:308-320(2012).
RN   [8]
RP   FUNCTION, INTERACTION WITH SHH, AND SUBUNIT.
RX   PubMed=22677548; DOI=10.1101/gad.191866.112;
RA   Creanga A., Glenn T.D., Mann R.K., Saunders A.M., Talbot W.S., Beachy P.A.;
RT   "Scube/You activity mediates release of dually lipid-modified Hedgehog
RT   signal in soluble form.";
RL   Genes Dev. 26:1312-1325(2012).
RN   [9]
RP   INTERACTION WITH SHH, FUNCTION, SUBUNIT, AND DOMAIN.
RX   PubMed=24522195; DOI=10.1242/jcs.137695;
RA   Jakobs P., Exner S., Schuermann S., Pickhinke U., Bandari S., Ortmann C.,
RA   Kupich S., Schulz P., Hansen U., Seidler D.G., Grobe K.;
RT   "Scube2 enhances proteolytic Shh processing from the surface of Shh-
RT   producing cells.";
RL   J. Cell Sci. 127:1726-1737(2014).
RN   [10]
RP   REVIEW.
RX   PubMed=26875496; DOI=10.1016/j.ydbio.2016.02.009;
RA   Xavier G.M., Seppala M., Barrell W., Birjandi A.A., Geoghegan F.,
RA   Cobourne M.T.;
RT   "Hedgehog receptor function during craniofacial development.";
RL   Dev. Biol. 415:198-215(2016).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH VEGFR2.
RX   PubMed=27834687; DOI=10.1161/atvbaha.116.308546;
RA   Lin Y.C., Chao T.Y., Yeh C.T., Roffler S.R., Kannagi R., Yang R.B.;
RT   "Endothelial SCUBE2 interacts with VEGFR2 and regulates VEGF-induced
RT   angiogenesis.";
RL   Arterioscler. Thromb. Vasc. Biol. 37:144-155(2017).
RN   [12]
RP   INTERACTION WITH SCUBE3.
RX   PubMed=33308444; DOI=10.1016/j.ajhg.2020.11.015;
RG   Genomics England Research Consortium;
RA   Lin Y.C., Niceta M., Muto V., Vona B., Pagnamenta A.T., Maroofian R.,
RA   Beetz C., van Duyvenvoorde H., Dentici M.L., Lauffer P., Vallian S.,
RA   Ciolfi A., Pizzi S., Bauer P., Gruening N.M., Bellacchio E.,
RA   Del Fattore A., Petrini S., Shaheen R., Tiosano D., Halloun R.,
RA   Pode-Shakked B., Albayrak H.M., Isik E., Wit J.M., Dittrich M.,
RA   Freire B.L., Bertola D.R., Jorge A.A.L., Barel O., Sabir A.H.,
RA   Al Tenaiji A.M.J., Taji S.M., Al-Sannaa N., Al-Abdulwahed H., Digilio M.C.,
RA   Irving M., Anikster Y., Bhavani G.S.L., Girisha K.M., Haaf T., Taylor J.C.,
RA   Dallapiccola B., Alkuraya F.S., Yang R.B., Tartaglia M.;
RT   "SCUBE3 loss-of-function causes a recognizable recessive developmental
RT   disorder due to defective bone morphogenetic protein signaling.";
RL   Am. J. Hum. Genet. 108:115-133(2021).
RN   [13]
RP   FUNCTION.
RX   PubMed=35231446; DOI=10.1016/j.devcel.2022.02.008;
RA   Huang P., Wierbowski B.M., Lian T., Chan C., Garcia-Linares S., Jiang J.,
RA   Salic A.;
RT   "Structural basis for catalyzed assembly of the Sonic hedgehog-Patched1
RT   signaling complex.";
RL   Dev. Cell 57:670-685(2022).
CC   -!- FUNCTION: Lipid-binding protein carrier required for sonic hedgehog
CC       (SHH) long-range signaling: binds to the dually lipid-modified Sonic
CC       hedgehog protein N-product (ShhN) and promotes its release from
CC       producing cells, allowing it to act as a morphogen for distant
CC       signaling (PubMed:19480626, PubMed:22677548, PubMed:22902404,
CC       PubMed:35231446). ShhN is then transferred to the CDON-BOC heterodimer
CC       and GAS1 coreceptors to reach its target, the patched receptor (PTCH1
CC       or PTCH2), followed by activation of the smoothened signaling pathway
CC       (PubMed:35231446). May also enhance the proteolytic processing
CC       (shedding) of the lipid-modified N- and C- terminal of ShhNp at the
CC       cell surface (PubMed:24522195). Synergizes with DISP1 to increase SHH
CC       secretion (PubMed:22902404). Probable cell surface coreceptor for
CC       VEGFR2 involved in VEGFR2-mediated angiogenesis (PubMed:27834687).
CC       {ECO:0000269|PubMed:19480626, ECO:0000269|PubMed:22677548,
CC       ECO:0000269|PubMed:22902404, ECO:0000269|PubMed:24522195,
CC       ECO:0000269|PubMed:27834687, ECO:0000269|PubMed:35231446}.
CC   -!- SUBUNIT: Forms homooligomers (PubMed:19480626). Forms heterooligomers
CC       with SCUBE1 (PubMed:19480626). Forms heterooligomers with SCUBE3
CC       (PubMed:33308444). Interacts with SHH via the cholesterol anchor of the
CC       dually lipid-modified SHH (ShhNp) (PubMed:19480626, PubMed:22677548,
CC       PubMed:22902404). Interacts with PTCH1 (PubMed:19480626). Interacts
CC       with VEGFR2 (PubMed:27834687). {ECO:0000269|PubMed:19480626,
CC       ECO:0000269|PubMed:22677548, ECO:0000269|PubMed:22902404,
CC       ECO:0000269|PubMed:27834687, ECO:0000269|PubMed:33308444}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:19480626}. Cell
CC       surface {ECO:0000269|PubMed:19480626}. Note=Secreted and tethered at
CC       the cell surface. {ECO:0000269|PubMed:19480626}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9NQ36-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NQ36-2; Sequence=VSP_021294, VSP_039955;
CC       Name=3;
CC         IsoId=Q9NQ36-3; Sequence=VSP_021293, VSP_021295;
CC   -!- TISSUE SPECIFICITY: Expressed in a broad spectrum of adult tissues
CC       (PubMed:12270931). {ECO:0000269|PubMed:12270931}.
CC   -!- DOMAIN: The CUB domain is important for the interaction with the
CC       cholesterol-anchor of SHH (PubMed:24522195). The CUB domain regulates
CC       protease recruitment and activation during SHH shedding
CC       (PubMed:24522195). {ECO:0000269|PubMed:24522195}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:19480626}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ400877; CAB92285.1; -; Genomic_DNA.
DR   EMBL; AK123039; BAC85521.1; -; mRNA.
DR   EMBL; AC079296; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC111690; AAI11691.1; -; mRNA.
DR   CCDS; CCDS53599.1; -. [Q9NQ36-3]
DR   CCDS; CCDS7797.2; -. [Q9NQ36-2]
DR   CCDS; CCDS81553.1; -. [Q9NQ36-1]
DR   RefSeq; NP_001164161.1; NM_001170690.3. [Q9NQ36-3]
DR   RefSeq; NP_001317128.1; NM_001330199.3. [Q9NQ36-1]
DR   RefSeq; NP_066025.2; NM_020974.4. [Q9NQ36-2]
DR   AlphaFoldDB; Q9NQ36; -.
DR   BioGRID; 121754; 2.
DR   CORUM; Q9NQ36; -.
DR   FunCoup; Q9NQ36; 149.
DR   IntAct; Q9NQ36; 1.
DR   NDEx; IQUERY-CP-SCUBE2; 2 NDEx IQuery Curated Pathways.
DR   STRING; 9606.ENSP00000310658; -.
DR   GlyConnect; Q9NQ36; 1 N-Linked glycan (1 site).
DR   GlyCosmos; Q9NQ36; 3 sites, 1 glycan.
DR   GlyGen; Q9NQ36; 5 sites, 1 N-linked glycan (1 site), 2 O-linked glycans (2 sites).
DR   iPTMnet; Q9NQ36; -.
DR   PhosphoSitePlus; Q9NQ36; -.
DR   BioMuta; SCUBE2; -.
DR   DMDM; 311033510; -.
DR   jPOST; Q9NQ36; -.
DR   MassIVE; Q9NQ36; -.
DR   PaxDb; 9606-ENSP00000310658; -.
DR   PeptideAtlas; Q9NQ36; -.
DR   ProteomicsDB; 82071; -. [Q9NQ36-1]
DR   ProteomicsDB; 82072; -. [Q9NQ36-2]
DR   ProteomicsDB; 82073; -. [Q9NQ36-3]
DR   Antibodypedia; 1601; 189 antibodies from 28 providers.
DR   DNASU; 57758; -.
DR   Ensembl; ENST00000309263.7; ENSP00000310658.3; ENSG00000175356.15. [Q9NQ36-1]
DR   Ensembl; ENST00000450649.6; ENSP00000415187.2; ENSG00000175356.15. [Q9NQ36-3]
DR   Ensembl; ENST00000520467.5; ENSP00000429969.1; ENSG00000175356.15. [Q9NQ36-2]
DR   GeneID; 57758; -.
DR   KEGG; hsa:57758; -.
DR   UCSC; uc001mhj.3; human. [Q9NQ36-1]
DR   AGR; HGNC:30425; -.
DR   ClinPGx; PA134908812; -.
DR   CTD; 57758; -.
DR   DisGeNET; 57758; -.
DR   GeneCards; SCUBE2; -.
DR   HGNC; HGNC:30425; SCUBE2.
DR   HPA; ENSG00000175356; Tissue enhanced (epididymis).
DR   MalaCards; SCUBE2; -.
DR   MIM; 611747; gene.
DR   OpenTargets; ENSG00000175356; -.
DR   VEuPathDB; HostDB:ENSG00000175356; -.
DR   GeneTree; ENSGT00940000153185; -.
DR   HOGENOM; CLU_013079_0_0_1; -.
DR   InParanoid; Q9NQ36; -.
DR   OrthoDB; 4062651at2759; -.
DR   PAN-GO; Q9NQ36; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; Q9NQ36; -.
DR   PathwayCommons; Q9NQ36; -.
DR   Reactome; R-HSA-5362798; Release of Hh-Np from the secreting cell.
DR   Agora; ENSG00000175356; -.
DR   BioGRID-ORCS; 57758; 10 hits in 1148 CRISPR screens.
DR   ChiTaRS; SCUBE2; human.
DR   GenomeRNAi; 57758; -.
DR   Pharos; Q9NQ36; Tbio.
DR   PRO; PR:Q9NQ36; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q9NQ36; protein.
DR   Bgee; ENSG00000175356; Expressed in corpus epididymis and 133 other cell types or tissues.
DR   ExpressionAtlas; Q9NQ36; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0140597; F:protein carrier activity; IDA:UniProtKB.
DR   GO; GO:0030509; P:BMP signaling pathway; IBA:GO_Central.
DR   GO; GO:0055001; P:muscle cell development; IBA:GO_Central.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007224; P:smoothened signaling pathway; IBA:GO_Central.
DR   CDD; cd00041; CUB; 1.
DR   CDD; cd00054; EGF_CA; 1.
DR   FunFam; 2.10.25.10:FF:000032; signal peptide, CUB and EGF-like domain-containing protein 2 isoform X1; 1.
DR   FunFam; 2.10.50.10:FF:000002; signal peptide, CUB and EGF-like domain-containing protein 2 isoform X1; 1.
DR   FunFam; 2.10.25.10:FF:000199; signal peptide, CUB and EGF-like domain-containing protein 2 isoform X2; 1.
DR   FunFam; 2.10.25.10:FF:000237; Signal peptide, CUB domain and EGF like domain containing 2; 1.
DR   FunFam; 2.10.25.10:FF:000256; Signal peptide, CUB domain and EGF like domain containing 2; 1.
DR   FunFam; 2.10.50.10:FF:000028; Signal peptide, CUB domain and EGF like domain containing 2; 1.
DR   FunFam; 2.10.50.10:FF:000029; Signal peptide, CUB domain and EGF like domain containing 2; 1.
DR   FunFam; 2.10.25.10:FF:000028; Signal peptide, CUB domain and EGF-like domain-containing 2; 1.
DR   FunFam; 2.10.25.10:FF:000030; Signal peptide, CUB domain and EGF-like domain-containing 2; 1.
DR   FunFam; 2.10.25.10:FF:000035; Signal peptide, CUB domain and EGF-like domain-containing 2; 1.
DR   FunFam; 2.10.25.10:FF:000037; Signal peptide, CUB domain and EGF-like domain-containing 2; 1.
DR   FunFam; 2.60.120.290:FF:000002; Signal peptide, CUB domain and EGF-like domain-containing 2; 1.
DR   FunFam; 2.10.25.10:FF:000008; Signal peptide, CUB domain, EGF-like 2; 1.
DR   Gene3D; 2.10.25.10; Laminin; 9.
DR   Gene3D; 2.60.120.290; Spermadhesin, CUB domain; 1.
DR   Gene3D; 2.10.50.10; Tumor Necrosis Factor Receptor, subunit A, domain 2; 3.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR000742; EGF.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR024731; NELL2-like_EGF.
DR   InterPro; IPR049883; NOTCH1_EGF-like.
DR   InterPro; IPR052071; SCUB_EGF-like_domain.
DR   InterPro; IPR035914; Sperma_CUB_dom_sf.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   PANTHER; PTHR24046; SIGNAL PEPTIDE, CUB AND EGF-LIKE DOMAIN-CONTAINING; 1.
DR   PANTHER; PTHR24046:SF3; SIGNAL PEPTIDE, CUB AND EGF-LIKE DOMAIN-CONTAINING PROTEIN 2; 1.
DR   Pfam; PF12662; cEGF; 1.
DR   Pfam; PF00431; CUB; 1.
DR   Pfam; PF12947; EGF_3; 1.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF07699; Ephrin_rec_like; 3.
DR   Pfam; PF14670; FXa_inhibition; 4.
DR   SMART; SM00042; CUB; 1.
DR   SMART; SM00181; EGF; 10.
DR   SMART; SM00179; EGF_CA; 8.
DR   SMART; SM01411; Ephrin_rec_like; 3.
DR   SUPFAM; SSF57196; EGF/Laminin; 1.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 4.
DR   SUPFAM; SSF49854; Spermadhesin, CUB domain; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 6.
DR   PROSITE; PS01180; CUB; 1.
DR   PROSITE; PS01186; EGF_2; 8.
DR   PROSITE; PS50026; EGF_3; 4.
DR   PROSITE; PS01187; EGF_CA; 6.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Developmental protein; Disulfide bond;
KW   EGF-like domain; Glycoprotein; Lipid-binding; Proteomics identification;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..31
FT                   /evidence="ECO:0000255"
FT   CHAIN           32..999
FT                   /note="Signal peptide, CUB and EGF-like domain-containing
FT                   protein 2"
FT                   /id="PRO_0000255580"
FT   DOMAIN          45..85
FT                   /note="EGF-like 1; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          86..127
FT                   /note="EGF-like 2; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          128..168
FT                   /note="EGF-like 3; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          177..213
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          217..252
FT                   /note="EGF-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          286..321
FT                   /note="EGF-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          323..363
FT                   /note="EGF-like 7; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          364..402
FT                   /note="EGF-like 8; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          403..443
FT                   /note="EGF-like 9; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          809..921
FT                   /note="CUB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   REGION          847..856
FT                   /note="Interaction with the cholesterol-anchor of SHH"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JJS0"
FT   CARBOHYD        659
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        49..62
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        56..71
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        73..84
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        90..102
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        98..111
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        113..126
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        368..378
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        374..387
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        389..401
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        407..418
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        414..427
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        429..442
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DISULFID        809..835
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   DISULFID        862..883
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   VAR_SEQ         444..569
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_021293"
FT   VAR_SEQ         482
FT                   /note="S -> SGLQGAYSVTCGSSSPLRNKQQKSNDSAFG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_021294"
FT   VAR_SEQ         639..695
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_039955"
FT   VAR_SEQ         806..872
FT                   /note="NRRCGGELGDFTGYIESPNYPGNYPANTECTWTINPPPKRRILIVVPEIFLP
FT                   IEDDCGDYLVMRKTS -> T (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_021295"
FT   VARIANT         591
FT                   /note="T -> M (in dbSNP:rs3751055)"
FT                   /evidence="ECO:0000269|PubMed:14702039"
FT                   /id="VAR_028870"
FT   VARIANT         712
FT                   /note="Q -> H (in dbSNP:rs7395988)"
FT                   /id="VAR_028871"
FT   VARIANT         752
FT                   /note="V -> G (in dbSNP:rs12419343)"
FT                   /id="VAR_028872"
FT   VARIANT         791
FT                   /note="T -> S (in dbSNP:rs3751057)"
FT                   /id="VAR_028873"
FT   VARIANT         843
FT                   /note="P -> R (in dbSNP:rs3751059)"
FT                   /id="VAR_028874"
FT   CONFLICT        916
FT                   /note="V -> G (in Ref. 2; BAC85521)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   999 AA;  109957 MW;  61334844A0053095 CRC64;
     MGVAGRNRPG AAWAVLLLLL LLPPLLLLAG AVPPGRGRAA GPQEDVDECA QGLDDCHADA
     LCQNTPTSYK CSCKPGYQGE GRQCEDIDEC GNELNGGCVH DCLNIPGNYR CTCFDGFMLA
     HDGHNCLDVD ECLENNGGCQ HTCVNVMGSY ECCCKEGFFL SDNQHTCIHR SEEGLSCMNK
     DHGCSHICKE APRGSVACEC RPGFELAKNQ RDCILTCNHG NGGCQHSCDD TADGPECSCH
     PQYKMHTDGR SCLEREDTVL EVTESNTTSV VDGDKRVKRR LLMETCAVNN GGCDRTCKDT
     STGVHCSCPV GFTLQLDGKT CKDIDECQTR NGGCDHFCKN IVGSFDCGCK KGFKLLTDEK
     SCQDVDECSL DRTCDHSCIN HPGTFACACN RGYTLYGFTH CGDTNECSIN NGGCQQVCVN
     TVGSYECQCH PGYKLHWNKK DCVEVKGLLP TSVSPRVSLH CGKSGGGDGC FLRCHSGIHL
     SSDVTTIRTS VTFKLNEGKC SLKNAELFPE GLRPALPEKH SSVKESFRYV NLTCSSGKQV
     PGAPGRPSTP KEMFITVEFE LETNQKEVTA SCDLSCIVKR TEKRLRKAIR TLRKAVHREQ
     FHLQLSGMNL DVAKKPPRTS ERQAESCGVG QGHAENQCVS CRAGTYYDGA RERCILCPNG
     TFQNEEGQMT CEPCPRPGNS GALKTPEAWN MSECGGLCQP GEYSADGFAP CQLCALGTFQ
     PEAGRTSCFP CGGGLATKHQ GATSFQDCET RVQCSPGHFY NTTTHRCIRC PVGTYQPEFG
     KNNCVSCPGN TTTDFDGSTN ITQCKNRRCG GELGDFTGYI ESPNYPGNYP ANTECTWTIN
     PPPKRRILIV VPEIFLPIED DCGDYLVMRK TSSSNSVTTY ETCQTYERPI AFTSRSKKLW
     IQFKSNEGNS ARGFQVPYVT YDEDYQELIE DIVRDGRLYA SENHQEILKD KKLIKALFDV
     LAHPQNYFKY TAQESREMFP RSFIRLLRSK VSRFLRPYK
//
DBGET integrated database retrieval system